Progressive cephalohematoma in a neonate revealing severe hemophilia a owing to intron 22 inversion: a case report

BackgroundHemophilia A is a rare X-linked recessive bleeding disorder characterized by coagulation factor VIII (FVIII) deficiency or dysfunction. While most cases present during early childhood with joint or soft tissue bleeding, neonatal-onset hemophilia A is uncommon and often difficult to diagnos...

Full description

Saved in:
Bibliographic Details
Main Authors: Cheng Peng, Qiuyue Kou, Qianqian Xia, Zhongfen Cao, Lili Liu, Xinlin Hou, Zezhong Tang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-07-01
Series:Frontiers in Pediatrics
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fped.2025.1649183/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849317595751120896
author Cheng Peng
Qiuyue Kou
Qianqian Xia
Zhongfen Cao
Lili Liu
Lili Liu
Xinlin Hou
Zezhong Tang
author_facet Cheng Peng
Qiuyue Kou
Qianqian Xia
Zhongfen Cao
Lili Liu
Lili Liu
Xinlin Hou
Zezhong Tang
author_sort Cheng Peng
collection DOAJ
description BackgroundHemophilia A is a rare X-linked recessive bleeding disorder characterized by coagulation factor VIII (FVIII) deficiency or dysfunction. While most cases present during early childhood with joint or soft tissue bleeding, neonatal-onset hemophilia A is uncommon and often difficult to diagnose owing to its nonspecific symptoms. Early recognition and a multidisciplinary management approach are critical for preventing life-threatening complications.Case PresentationWe report a case of a male neonate admitted on day 8 of life with progressive jaundice. Physical examination revealed a large cephalohematoma and multiple skin ecchymomas. Laboratory evaluation revealed anemia and a markedly prolonged activated partial thromboplastin time (APTT). APTT mixing studies indicated factor deficiency, and factor VIII activity was <1%, confirming severe hemophilia A. Genetic analysis identified an intron 22 inversion in the F8 gene. Initial treatment included fresh frozen plasma, plasma-derived and recombinant factor VIII replacement, and phototherapy. After stabilization, the patient was transitioned to prophylactic emicizumab, which was well tolerated. At 6 weeks of age, the hematoma had nearly resolved with no further bleeding episodes observed.ConclusionEarly-onset hemophilia A in neonates may present with subtle or atypical symptoms, requiring a high index of suspicion and comprehensive diagnostic evaluation. This case underscores the value of combining functional coagulation assays and molecular testing to confirm diagnosis. It also highlights the potential benefits of early initiation of non-factor prophylaxis. Collaborative cross-disciplinary care is essential to achieve optimal outcomes in neonatal patients with bleeding disorders.
format Article
id doaj-art-81e9679becbb4a528b8a90a81813db21
institution Kabale University
issn 2296-2360
language English
publishDate 2025-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pediatrics
spelling doaj-art-81e9679becbb4a528b8a90a81813db212025-08-20T03:51:09ZengFrontiers Media S.A.Frontiers in Pediatrics2296-23602025-07-011310.3389/fped.2025.16491831649183Progressive cephalohematoma in a neonate revealing severe hemophilia a owing to intron 22 inversion: a case reportCheng Peng0Qiuyue Kou1Qianqian Xia2Zhongfen Cao3Lili Liu4Lili Liu5Xinlin Hou6Zezhong Tang7Department of Neonatology, Peking University First Hospital, Beijing, ChinaDepartment of Pediatrics, The Second Affiliated Hospital of Qiqihar Medical University, Qiqihar, ChinaDepartment of Neonatology, Peking University First Hospital, Beijing, ChinaDepartment of Neonatology, Peking University First Hospital, Beijing, ChinaDepartment of Neonatology, Peking University First Hospital, Beijing, ChinaDepartment of Neonatology, PKUFH-NINGXIA Women & Children’s Hospital, Yinchuan, ChinaDepartment of Neonatology, Peking University First Hospital, Beijing, ChinaDepartment of Neonatology, Peking University First Hospital, Beijing, ChinaBackgroundHemophilia A is a rare X-linked recessive bleeding disorder characterized by coagulation factor VIII (FVIII) deficiency or dysfunction. While most cases present during early childhood with joint or soft tissue bleeding, neonatal-onset hemophilia A is uncommon and often difficult to diagnose owing to its nonspecific symptoms. Early recognition and a multidisciplinary management approach are critical for preventing life-threatening complications.Case PresentationWe report a case of a male neonate admitted on day 8 of life with progressive jaundice. Physical examination revealed a large cephalohematoma and multiple skin ecchymomas. Laboratory evaluation revealed anemia and a markedly prolonged activated partial thromboplastin time (APTT). APTT mixing studies indicated factor deficiency, and factor VIII activity was <1%, confirming severe hemophilia A. Genetic analysis identified an intron 22 inversion in the F8 gene. Initial treatment included fresh frozen plasma, plasma-derived and recombinant factor VIII replacement, and phototherapy. After stabilization, the patient was transitioned to prophylactic emicizumab, which was well tolerated. At 6 weeks of age, the hematoma had nearly resolved with no further bleeding episodes observed.ConclusionEarly-onset hemophilia A in neonates may present with subtle or atypical symptoms, requiring a high index of suspicion and comprehensive diagnostic evaluation. This case underscores the value of combining functional coagulation assays and molecular testing to confirm diagnosis. It also highlights the potential benefits of early initiation of non-factor prophylaxis. Collaborative cross-disciplinary care is essential to achieve optimal outcomes in neonatal patients with bleeding disorders.https://www.frontiersin.org/articles/10.3389/fped.2025.1649183/fullhemophilia AcephalohematomaneonateF8 geneemicizumab
spellingShingle Cheng Peng
Qiuyue Kou
Qianqian Xia
Zhongfen Cao
Lili Liu
Lili Liu
Xinlin Hou
Zezhong Tang
Progressive cephalohematoma in a neonate revealing severe hemophilia a owing to intron 22 inversion: a case report
Frontiers in Pediatrics
hemophilia A
cephalohematoma
neonate
F8 gene
emicizumab
title Progressive cephalohematoma in a neonate revealing severe hemophilia a owing to intron 22 inversion: a case report
title_full Progressive cephalohematoma in a neonate revealing severe hemophilia a owing to intron 22 inversion: a case report
title_fullStr Progressive cephalohematoma in a neonate revealing severe hemophilia a owing to intron 22 inversion: a case report
title_full_unstemmed Progressive cephalohematoma in a neonate revealing severe hemophilia a owing to intron 22 inversion: a case report
title_short Progressive cephalohematoma in a neonate revealing severe hemophilia a owing to intron 22 inversion: a case report
title_sort progressive cephalohematoma in a neonate revealing severe hemophilia a owing to intron 22 inversion a case report
topic hemophilia A
cephalohematoma
neonate
F8 gene
emicizumab
url https://www.frontiersin.org/articles/10.3389/fped.2025.1649183/full
work_keys_str_mv AT chengpeng progressivecephalohematomainaneonaterevealingseverehemophiliaaowingtointron22inversionacasereport
AT qiuyuekou progressivecephalohematomainaneonaterevealingseverehemophiliaaowingtointron22inversionacasereport
AT qianqianxia progressivecephalohematomainaneonaterevealingseverehemophiliaaowingtointron22inversionacasereport
AT zhongfencao progressivecephalohematomainaneonaterevealingseverehemophiliaaowingtointron22inversionacasereport
AT lililiu progressivecephalohematomainaneonaterevealingseverehemophiliaaowingtointron22inversionacasereport
AT lililiu progressivecephalohematomainaneonaterevealingseverehemophiliaaowingtointron22inversionacasereport
AT xinlinhou progressivecephalohematomainaneonaterevealingseverehemophiliaaowingtointron22inversionacasereport
AT zezhongtang progressivecephalohematomainaneonaterevealingseverehemophiliaaowingtointron22inversionacasereport